Skip to search formSkip to main contentSkip to account menu

bimatoprost 0.1 MG/ML Ophthalmic Solution [Lumigan]

Known as: LUMIGAN 0.01 % Ophthalmic Solution, Lumigan 0.1 MG/ML Ophthalmic Solution, bimatoprost 0.1 mg in 1 mL OPHTHALMIC SOLUTION/ DROPS [LUMIGAN] 
National Institutes of Health

Related topics

Related topics

11 relations
Benzalkonium ChlorideHydrochloric AcidLumiganOphthalmic Solution

Broader (1)

bimatoprost Ophthalmic Solution [Lumigan]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Schleichende Visusverschlechterung bei Sekundärglaukom
Eine 55-jahrige gesunde Patientin wunscht eine Zweitmeinung wegen einseitiger zunehmender Visusverschlechterung seit 2 Monaten… 
2006
2006
Zystoides Makulaödem bei Pseudophakie nach mehreren drucksenkenden Eingriffen. Ist die lokale Medikation von Bimatoprost die Ursache?
Hintergrund: Patient: Ergebnisse: Schlussfolgerung: Background: Patient: . Results: Conclusion: , 
2004
2004
An update on bimatoprost (Lumigan®) in glaucoma therapy
The prostamide bimatoprost (Lumigan®, Allergan Inc.) has been proven highly effective as monotherapy, adjunctive, and replacement… 
2002
2002
AGN 192024 (Lumigan®): a Synthetic Prostamide Analog that Lowers Primate Intraocular Pressure by Virtue of Its Inherent Pharmacological Activity
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)